Delivery Order SPE2DE24D0013-SPE2D625F3TJD
- Not listed
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $4,568.25 to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Logistics Agency (operating under the Medical Supply Chain division) awarded a $4,993.20 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for a Nuclear Acid Expert 10S kit. The contract, awarded on June 18, 2025, with an ultimate completion date of July 2, 2025, carries no set-aside designation. This delivery order represents a near-term procurement of diagnostic testing solutions from Cepheid, a leading...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3TJDDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $3,460.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, with an ultimate completion date of September 24, 2025. This delivery order, which carries no set-aside designation, is part of Cepheid's broader federal contracting portfolio providing advanced diagnostic systems and test kits for infectious disease detection and clinical testing across multiple federal healthcare entities. The award reflects the company's established position as a supplier of molecular diagnostic solutions to defense and Veterans Affairs customers. This delivery order likely falls under one of Cepheid's two significant Indefinite Delivery Vehicle contracts held with the VA's Veterans Integrated Service Networks, which collectively provide frameworks for procuring PCR testing systems, reagents, and assays. Cepheid's core offerings include GeneXpert diagnostic systems and associated molecular reagents designed to detect conditions including COVID-19, influenza, RSV, and other infectious diseases. The relatively modest delivery order value indicates a specific, discrete procurement of diagnostic equipment, reagents, or related services within the larger IDV structure, supporting the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/17/25 |